Journal of the American Chemical Society
Page 4 of 5
7.
In transition metal catalyzed allylation reactions,
ASSOCIATED CONTENT
counterions were generally introduced by employing different leaving
groups, which restricted the scope of counterions.
8.
1
2
Experimental procedures and characterization data. This material
For stoichiometric study on silver salt promoted formation
3
4
5
6
7
8
9
of metallacyclic iridium allylcomplex, see: (a) Madrahimov, S. T.;
Markovic, D.; Hartwig, J. F. J. Am. Chem. Soc. 2009, 131, 7228; (b)
Raskatov, J. A.; Spiess, S.; Gnamm, C.; Broedner, K.; Rominger, F.;
AUTHOR INFORMATION
Corresponding Author
Helmchen, G. Chem.--Eur. J. 2010, 16, 6601; For
a
Notes
cycloisomerisation catalyzed by an iridium chiral phosphate complex,
see: (c) Barbazanges, M.; Augé, M.; Moussa, J.; Amouri, H.; Aubert,
C.; Desmarets, C.; Fensterbank, L.; Gandon, V.; Malacria, M.;
Ollivier, C. Chem.-Eur. J. 2011, 17, 13789.
The authors declare no competing financial interest.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9.
10.
Tanaka, M. Chem. Pharm. Bull 2007, 55, 349.
For a review on azlactones in enantioselective reactions,
ACKNOWLEDGMENT
We thank the NIH (GM-58108) for support of this work, Johnson-
Matthey for gifts of [Ir(cod)Cl]2, and Dr. Klaus Ditrich and BASF
for gifts of chiral amines. W. C. thanks Dr. Ming Chen for helpful
discussions.
see: (a) Alba, A.-N. R.; Rios, R. Chem. -Asian J. 2011, 6, 720; For a
Mo-catalyzed asymmetric allylation of azlactones, see: (b) Trost, B.
M.; Dogra, K. J. Am. Chem. Soc. 2002, 124, 7256; For a Pd-catalyzed
asymmetric allylation of azlactones to form linear products, see: (c)
Trost, B. M.; Ariza, X. J. Am. Chem. Soc. 1999, 121, 10727. For an
[Ir(cod)Cl]2 catalyzed allylation/aza-Cope sequence with azlactones,
see: (d) Kawatsura, M.; Tsuji, H.; Uchida, K.; Itoh, T. Tetrahedron
2011, 67, 7686.
REFERENCES
1.
For reviews on Ir-catalyzed asymmetric allylation, see: (a)
Hartwig, J. F.; Stanley, L. M. Acc. Chem. Res. 2010, 43, 1461; (b)
Tosatti, P.; Nelson, A.; Marsden, S. P. Org. Biomol. Chem. 2012, 10,
3147; (c) Liu, W.-B.; Xia, J.-B.; You, S.-L. Top. Organomet. Chem.
2012, 38, 155; (d) Hartwig, J. F.; Pouy, M. J. Top. Organomet. Chem.
2011, 34, 169; (e) Helmchen, G., In Iridium Complexes in Organic
Synthesis; Oro, L. A.; Claver, C., Eds.; Wiley-VCH: Weinheim,
Germany, 2009; pp 211; For a review on phosphoramidite ligand in
asymmetric catalysis, see: (f) Teichert, J. F.; Feringa, B. L. Angew.
Chem., Int. Ed. 2010, 49, 2486.
11.
Unless otherwise noted, 2.20 equiv 3 was used because
methanol formed in the reaction reacted with 3 to form the methyl
ester.
12.
biphenol, see: (a) Wuennemann, S.; Froehlich, R.; Hoppe, D. Eur. J.
Org. Chem. 2008, 684; For an example of the phosphoric acid
catalyzed reaction, see: (b) Moreau, J.; Hubert, C.; Batany, J.; Toupet,
L.; Roisnel, T.; Hurvois, J.-P.; Renaud, J.-L. J. Org. Chem. 2009, 74,
8963.
See the SI for the synthesis of 2c. For the preparation of the
2.
For moderately diastereoselective allylations catalyzed by
13.
Liu, W.-B.; Zheng, C.; Zhuo, C.-X.; Dai, L.-X.; You, S.-L.
an iridium phosphite complex, see: (a) Kanayama, T.; Yoshida, K.;
Miyabe, H.; Takemoto, Y. Angew. Chem., Int. Ed. 2003, 42, 2054; (b)
Kanayama, T.; Yoshida, K.; Miyabe, H.; Kimachi, T.; Takemoto, Y.
J. Org. Chem. 2003, 68, 6197; For an intramolecular example with
good diastereoselectivity, see: (c) Wu, Q.-F.; Liu, W.-B.; Zhuo, C.-X.;
Rong, Z.-Q.; Ye, K.-Y.; You, S.-L. Angew. Chem., Int. Ed. 2011, 50,
4455.
J. Am. Chem. Soc. 2012, 134, 4812.
14.
15.
See the SI for a new route to DBCOT.
The anion contains both components with an IR band at
3372 cm-1 that is consistent with the stretch of a hydrogen bonded O-
H group.
16.
The absolute configuration of the allylation product was
determined by comparison of the optical rotation and retention time to
a literature value in reference 10d.
17.
Compounds as Monoamine Reuptake Inhibitors. WO2010123006A1,
2010.
3.
Unpublished results. For two reported examples, see: (a)
Dahnz, A.; Helmchen, G. Synlett 2006, 697; (b) Polet, D.; Alexakis,
A.; Tissot-Croset, K.; Corminboeuf, C.; Ditrich, K. Chem.-Eur. J.
2006, 12, 3596.
Yoshikawa, M.; Kamei, T. Preparation of Pyrrolidine
4.
J.; Hamilton, G. L.; Toste, F. D. Nature Chem. 2012, 4, 603.
5. Gnamm, C.; Förster, S.; Miller, N.; Brödner, K.; Helmchen,
G. Synlett 2007, 790.
For a review on chiral counterion strategy, see: Phipps, R.
6.
15249.
Chen, W.; Hartwig, J. F. J. Am. Chem. Soc. 2012, 134,
ACS Paragon Plus Environment